language-icon Old Web
English
Sign In
Acemap > Paper > Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases: SEQUENTIAL USE OF SORAFENIB AND SUNITINIB IN ADVANCED RCC

Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases: SEQUENTIAL USE OF SORAFENIB AND SUNITINIB IN ADVANCED RCC

2011 
Keywords:
    • Correction
    • Cite
    • Save
    • Machine Reading By IdeaReader
    29
    References
    0
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.